A Dose Regimen Study of BRM421 Ophthalmic Solution in Patients With Dry Eye Disease

Clinical trial NCT07078955 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07078955
Sponsor: BRIM Biotechnology Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Dry Eye Disease (DED)Keratoconjunctivitis Sicca

Start date: 2025-12-01
Primary completion: 2026-11-01
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.